Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kaleido Biosciences Inc

(NASDAQ: KLDO)
Add to Portfolio
+0.39 (+6.38%)
as of Nov 14, 2019

Last 6.50
Change +0.39 (+6.38%)
Open 6.15
Prev. Close 6.11
Today's Range
5.96
6.75
52wk Range
4.80
19.00
Volume 31,500
Avg Volume 49,030
Sector Medical - Biomedical

Perfomance Comparison

Name Today 3-Month 1-Year
KLDO +6.38% -26.72% -54.32%
DJIA -0.01% +3.94% +10.77%
S&P 500 +0.08% +4.05% +14.62%

Key Statistics

Annual EPS -2.82
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 38
Weighted Alpha -58.60
Standard Deviation +1.17
Profit Margin -185.29%
Beta -0.71

Growth Rates

YTD -54.32%

Opinion

Sell Hold Buy

Recent Headlines

Flagship Pioneering Appoints Prakash Raman, Ph.D. as

PR Newswire via COMTEX - Tue Nov 12, 08:00AM EST
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the appointment of Prakash Raman, Ph.D. to the post of Senior Partner and the newly created role of Chief Business Development Officer. Dr. Raman m(full story)
NVS: 89.51 (-0.35), AXLA: 3.58 (-0.25), DNLI: 15.00 (-0.15), EVLO: 6.15 (-0.18), KLDO: 6.50 (+0.39), MRNA: 18.34 (+0.09), RUBY: 7.88 (-1.96)

Kaleido Biosciences Announces Appointment of Jean

GlobeNewswire via COMTEX - Mon Sep 30, 08:01AM EDT
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced that Jean Mixer has been (full story)
KLDO: 6.50 (+0.39)

Kaleido Biosciences to Present at the Morgan Stanley

GlobeNewswire via COMTEX - Thu Aug 29, 08:00AM EDT
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced that management will part(full story)
MS: 48.61 (+0.22), KLDO: 6.50 (+0.39)

Kaleido Biosciences Announces Appointment of Theo

GlobeNewswire via COMTEX - Mon Jul 15, 08:00AM EDT
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced that The(full story)
KLDO: 6.50 (+0.39), EVLO: 6.15 (-0.18)

Kaleido Biosciences Announces Closing of Initial

GlobeNewswire via COMTEX - Mon Mar 04, 04:22PM EST
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today an(full story)
MS: 48.61 (+0.22), KLDO: 6.50 (+0.39)